The “Fair and Accurate Medicaid Pricing Act,” introduced by Sens. Maggie Hassan, D-N.H., and Bill Cassidy, MD, R-La., closes a loophole that allowed drugmakers to underpay rebates to Medicaid, which increased state and federal costs for prescription drugs.
The legislation no longer allows generic drugs to be used in calculations for the average manufacturer price. The senators predict this will save taxpayers approximately $3.1 billion over the next 10 years.
“This will fix a rigged system allowing companies to price gouge taxpayers and patients,” Sen. Cassidy said.
Read the full news release here.
More articles on pharmacy:
Following CVS, Walgreens and Rite Aid pull Zantac from shelves
Telemedicine startup to open first brick-and-mortar pharmacy
Top 10 pharmacy stories in September
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
